Adicet Bio, Inc.

NASDAQ:ACET

0.62 (USD) • At close April 29, 2025
Bedrijfsnaam Adicet Bio, Inc.
Symbool ACET
Munteenheid USD
Prijs 0.622
Beurswaarde 51,447,105
Dividendpercentage 0%
52-weken bereik 0.447 - 1.865
Industrie Biotechnology
Sector Healthcare
CEO Mr. Chen Schor BA, CPA, CPA, M.B.A., MBA
Website https://www.adicetbio.com

An error occurred while fetching data.

Over Adicet Bio, Inc.

Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and

Vergelijkbare Aandelen

Praxis Precision Medicines, Inc. logo

Praxis Precision Medicines, Inc.

PRAX

37.2 USD

Vaxart, Inc. logo

Vaxart, Inc.

VXRT

0.425 USD

Kinnate Biopharma Inc. logo

Kinnate Biopharma Inc.

KNTE

2.65 USD

Rallybio Corporation logo

Rallybio Corporation

RLYB

0.304 USD

Day One Biopharmaceuticals, Inc. logo

Day One Biopharmaceuticals, Inc.

DAWN

7.68 USD

Alpha Tau Medical Ltd. logo

Alpha Tau Medical Ltd.

DRTS

2.71 USD

IRadimed Corporation logo

IRadimed Corporation

IRMD

53.7 USD

RAPT Therapeutics, Inc. logo

RAPT Therapeutics, Inc.

RAPT

0.906 USD

Nuvalent, Inc. logo

Nuvalent, Inc.

NUVL

75.87 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)